Kintayl Capital Adds $7.6M Stake in NorthWestern Energy Group, Highlighting Utility's Strong Outlook

jueves, 4 de diciembre de 2025, 8:37 pm ET1 min de lectura
MRK--

Merck Animal Health's EXZOLT CATTLE-CA1 has received conditional FDA approval as a pour-on solution to prevent and treat infestations caused by New World screwworm larvae and cattle fever tick. The product contains the active ingredient fluralaner and is effective against infestations in beef cattle two months of age and older. It has a 98-day meat withdrawal period and will be available by prescription in the first quarter of 2026.

Kintayl Capital Adds $7.6M Stake in NorthWestern Energy Group, Highlighting Utility's Strong Outlook

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios